2nd Webinar on

Infectious Diseases & Immune System

October 21, 2021

2nd Infectious Diseases-2021

Theme: Novel remedy systems for COVID-19 and Infectious disorder Prevention control and fix

Meetings International is delighted to welcome all Infectious Diseases experts and delegates to participate in the 2nd Webinar on”Infectious Diseases & Immune System” which is going to be held in during October 21, 2021. Will be focusing on theme” Novel remedy systems for COVID-19 and Infectious disorder Prevention control and fix”

We cordially invite all the participants who are interested in sharing their knowledge and research in the area of Infectious-Diseases-2021. Anticipates more than 100 participants around the globe with thought provoking plenary sessions, keynote lectures, Oral Presentations and Poster Presentations. The attending delegates incorporate Editorial Board Members of related International Journals. This is a magnificent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists.

Session1: Infectious Diseases

Infectious Diseases are caused by micro-organisms like bacteria, viruses, fungi, or parasites. Most of the organisms will reside in and on our bodies. Those are usually harmless and helpful. In certain conditions, some organisms may cause disease and some other infectious diseases can be spread from person to person. Examples like SARS, Coronaviruses, Influenza, Diphtheria, HIV/AIDS, HPV, Tuberculosis (TB), Hepatitis A and B.

Session2: Coronavirus Disease (COVID-19)

Coronavirus Disease (COVID-19) is an infectious disease caused by a newly discovered Corona virus strain. The majority who fall sick with COVID-19 can experience delicate to moderate symptoms and recover without special treatment.

Coronaviruses are a bunch of similar RNA viruses that cause diseases in mammals and birds. In humans and birds, they cause tract infections that may vary from delicate to deadly. Mild sicknesses in humans include some cases of respiratory disease (which is additionally caused by different viruses, preponderantly rhinoviruses), whereas a lot of deadly varieties will cause SARS, MERS, and COVID-19. In cows and pigs, they cause diarrhea, whereas in mice they cause hepatitis and inflammation.

Session3: Current Paradigms in COVID-19 Research

Recent pandemic of coronavirus disease caused by a novel coronavirus SARS-CoV-2 in humans is the third outbreak by this family of viruses leading to an acute respiratory infection, which has been a major cause of morbidity and mortality worldwide.The virus belongs to the genus, Betacoronavirus, which has been recently reported to have significant similarity (>89%) to a severe acute respiratory syndrome (SARS)-related member of the Sarbecoviruses. Current researches are not sufficient to understand the etiological and immunopathobiological parameters related to COVID-19 so as to have a therapeutic solution to the problem.

Session4: Transmission of COVID- 19

Transmission of SARS-CoV-2 can occur through direct, indirect, or close contact with infected people through infected secretions such as saliva and respiratory secretions or their respiratory droplets, which are expelled when an infected person coughs, sneezes, talks or sings. When COVID-19 was clearly becoming a critical threat to many countries around the world, the evidence indicated that the virus spreads from person to person through small respiratory droplets produced when people cough or sneeze, or even breathe. These droplets tend to travel a few feet and then land on surfaces, where the virus could last for up to three days. This is why most of the advice to stop its transmission have centred on lockdowns, physical distancing, handwashing with soap, and the use of alcohol-based hand sanitising gels.

Session5: Research on Medicine and Vaccine for COVID-19

A COVID-19 vaccine is intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing coronavirus disease (COVID-19). Earlier to the COVID-19 pandemic, work to develop a vaccine against coronavirus diseases like severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS) established knowledge about the structure and function of coronaviruses, this knowledge enabled accelerated development of various vaccines.

Market Analysis:

Every year, lives are lost because of the spread of infections in hospitals. Health care workers can take steps to prevent the spread of infectious diseases. These steps are part of infection control.  Infection prevention and control measures aim to ensure the protection of those who might be vulnerable to acquiring an infection both in the general community and while receiving care due to health problems, in a range of settings. The basic principle of infection prevention and control is hygiene. Healthcare personnel might need to take additional infection control steps if a PUI or patient with confirmed EVD has other conditions or illnesses caused by specific infectious diseases, such as tuberculosis. Healthcare personnel can be exposed to Ebola virus by touching a patient’s body fluids, contaminated medical supplies and equipment, or contaminated environmental surfaces. Splashes to unprotected mucous membranes (for example, the eyes, nose, or mouth) are particularly hazardous. Procedures that can increase environmental contamination with infectious material or create aerosols should be minimized. healthcare personnel (HCP) refers all people, paid and unpaid, working in healthcare settings who have the potential for exposure to patients and/or to infectious materials, including body substances, contaminated medical supplies and equipment, contaminated environmental surfaces, or aerosols generated during certain medical procedures. HCP include, but are not limited to, physicians, nurses, nursing assistants, therapists, technicians, emergency medical service personnel, dental personnel, pharmacists, laboratory personnel, autopsy personnel, students and trainees, contractual personnel, home healthcare personnel, and people not directly involved in patient care (clerical, dietary, housekeeping, laundry, security, maintenance, billing, chaplains, and volunteers) but potentially exposed to infectious agents that can be transmitted to and from HCP and patients.

Infectious Diseases Analysis in Europe:
Europe Infectious Disease Diagnostics Market By Product & Service (Assays, Kits, Reagents, Instruments, Service & Software), Technology (Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarray, Other Technologies), Disease Type (Hepatitis, HIV, CT/NG, HAIS, HPV, TB, Influenza, Other Infectious Diseases), End User (Hospital/Clinical Laboratories, Reference Laboratories, Physician Offices, Academic/Research Institutes, Other End Users), Country (Germany, U.K., France, Spain, Italy, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest of Europe) – Industry Trends and Forecast to 2026

Europe infectious disease diagnostics market is registering a substantial CAGR in the forecast period of 2019-2026. The report contains data from the base year of 2018 and the historic year of 2017. The rise in the market can be attributed due to the surging demand for new diagnostic tests for the control of infectious diseases is contributing to market growth.
Members associated with Infectious Diseases
Centre for Infectious Diseases and Policy includes 218 members
Global Public Health is having 106913 members
Members Pediatric Infectious Disease and Immunology has 3291 members
European Society of Clinical Microbiology and Infectious Diseases has 3438 members
Infectious Diseases Society has 707 members
Worldwide Data
Worldwide members of Infectious are 3,683 members
European Congress in Clinical Microbiology and Infectious Diseases is having 1,369 members
National Foundation for Infectious Diseases has 365 members
UNC Institute for Global Health & Infectious Diseases has237 members
Cirion; bridging the gap in infectious diseases between science and society has55 members
HIV/AIDS & Infectious Diseases has 85 members
M.S. in Public Health Microbiology & Emerging Infectious Diseases has 44 members
Infectious Diseases and Public Health (IDPH) Research Group has 45 members
EUPHA Section Infectious diseases control has 38 members
Center for Structural Genomics of Infectious Diseases (CSGID) has30 members
LSHTM_Control of Infectious Diseases has 19 members
Societies and Associations related to Infectious Diseases
Healthcare Infection Society
European Society for Pediatric Infectious Diseases
European Society of Clinical Microbiology and Infectious Diseases
Infection Prevention Society
British Society for Immunology
British Infection Association
British Infection Association
European Society for pediatric Infectious diseases
Health care Infection Society
Worldwide societies for infectious diseases is about 150
Universities related to Infectious Diseases
University of Cambridge
Kings College of London
London School of Hygiene and Tropical Medicine
Imperial College London
UCL Institute of Epidemiology and Health care
University of Sheffeild
Pediatric Infectious Diseases Society
Columbia University
University of Maryland
Swedish Institute for Infectious Disease Control
Uppsala University
University of Gothenburg
University of Otago
Oslo University
University of Pittsburgh
Emory Health Sciences
Queensland University of Technology
University of Liverpool
University of Colorado Denver
Infectious Diseases Society of America
References
http://www.mayoclinic.org/diseases-conditions/infectious-diseases/basics/definition/con-   20033534
http://ije.oxfordjournals.org/content/32/5/684.full
http://www.jblearning.com/samples/0763728799/28799_CH01_001_022.pdf.

  • Infectious Diseases
  • Coronavirus Disease (COVID-19)
  • Current Paradigms in COVID-19 Research
  • Transmission of COVID- 19
  • Research on Medicine and Vaccine for COVID-19